UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 17, 2006
Longs Drug Stores Corporation
(Exact Name of Registrant as Specified in Charter)
Maryland | 1-8978 | 68-0048627 | ||
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
141 North Civic Drive Walnut Creek, California | 94596 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code (925) 937-1170
(Former Name or Former address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02 | Results of Operations and Financial Condition |
(a) On May 17, 2006 Longs Drug Stores Corporation issued a news release regarding its first quarter fiscal 2007 financial results and its second quarter and fiscal 2007 management outlook. The full text of the news release is furnished as an exhibit hereto and incorporated by reference herein. The information in this report shall be deemed incorporated by reference into any registration statement heretofore or hereafter filed under the Securities Act of 1933, as amended, except to the extent that such information is superseded by information as of a subsequent date that is included in or incorporated by reference into such registration statement. The information in this report shall not be treated as filed for purposes of the Securities Exchange Act of 1934, as amended.
Item 9.01 | Financial Statements and Exhibits. |
(d) The following exhibits are being furnished as part of this Form 8-K:
Number | Exhibit | |
99.1 | News Release of Longs Drug Stores Corporation dated May 17, 2006. | |
99.2 | Longs Drug Stores Corporation Statements of Consolidated Income (Unaudited) Retrospective Application of FSP FAS 13-1 for fiscal 2006. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 17, 2006 | LONGS DRUG STORES CORPORATION | |||||||
(Registrant) | ||||||||
By: | /s/ Roger L. Chelemedos | |||||||
Name: | Roger L. Chelemedos | |||||||
Its: | Senior Vice President—Finance, (Principal Accounting Officer) |